Angiocentric lesions of the head and neck

Head and Neck Pathology

Volumn 2, Issue 2, 2008, Pages 116-130

  Magro, Cynthia M ^a   Dyrsen, Molly ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Allergic granulomatosis of Churg Strauss (AGCS); Angiocentric lesions; Chronic cocaine abuse; Eosinophilic angiocentric fibrosis (EAF); Head; Lymphomatoid granulomatosis (LYG); Microscopic polyarteritis (PAN); Natural killer T cell lymphomas; Neck; Relapsing polychondritis; Trigeminal trophic ulcer; Wegener's granulomatosis (WG)

Indexed keywords

B CELL LYMPHOMA; BLOOD VESSEL; CONFERENCE PAPER; HEAD AND NECK TUMOR; HUMAN; LYMPHOMATOID GRANULOMATOSIS; NASOPHARYNX TUMOR; NK T CELL LYMPHOMA; PATHOLOGY; PHARYNX DISEASE; RELAPSING POLYCHONDRITIS; SYSTEMIC VASCULITIS; VASCULARIZATION; WEGENER GRANULOMATOSIS;

BLOOD VESSELS; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, EXTRANODAL NK-T-CELL; LYMPHOMATOID GRANULOMATOSIS; NASOPHARYNGEAL DISEASES; NASOPHARYNGEAL NEOPLASMS; POLYCHONDRITIS, RELAPSING; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 77957331070     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-008-0049-2     Document Type: Review

References (75)

1. Pereira EM, Millas I, Reis-Filho JS, Maeda SA, Franco M. Eosinophilic angiocentric fibrosis of the sinonasal tract: report on the clinicopathologic features of a case and review of the literature. Head Neck. 2002;24(3):307-11.
2. Holmes DK, Panje WR. Intranasal granuloma faciale. Am J Otolaryngol. 1983;4(3):184-6.
3. LeBoit PE. Granuloma faciale: a diagnosis deserving of dignity. Am J Dermatopathol. 2002;24(5):440-3. Review.
4. Roberts PF, McCann BG. Eosinophilic angiocentric fibrosis of the upper respiratory tract: a mucosal variant of granuloma faciale? A report of three cases. Histopathology. 1985;9(11):1217-25.
5. Paun S, Lund VJ, Gallimore A. Nasal fibrosis: long-term follow up of four cases of eosinophilic angiocentric fibrosis. J Laryngol Otol. 2005;119(2):119-24. Review.
6. Burns BV, Roberts PF, De Carpentier J, Zarod AP. Eosinophilic angiocentric fibrosis affecting the nasal cavity. A mucosal variant of the skin lesion granuloma faciale. J Laryngol Otol. 2001;115(3): 223-6. Review.
7. Sheu SY, Wenzel RR, Kersting C, Merten R, Otterbach F, Schmid KW. Erdheim-Chester disease: case report with multisystemic manifestations including testes, thyroid, and lymph nodes, and a review of literature. J Clin Pathol. 2004;57(11):1225-8.
8. McCarthy JM, White VA, Harris G, Simons KB, Kennerdell J, Rootman J. Idiopathic sclerosing inflammation of the orbit: immunohistologic analysis and comparison with retroperitoneal fibrosis. Mod Pathol. 1993;6(5):581-7.
9. Holodny AI, Kirsch CF, Hameed M, Sclar G. Tumefactive fibroinflammatory lesion of the neck with progressive invasion of the meninges, skull base, orbit, and brain. AJNR Am J Neuroradiol. 2001;22(5):876-9.
10. Wegener F. Ueber generalisierte, septische Gefaesserkrankungen. Verh Dtsch Ges Pathol. 1936;36:202-10.
11. Kallenberg CG, Heeringa P, Stegeman CA. Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol. 2006;2(12):661-70.
12. Haubitz M. ANCA-associated vasculitis: diagnosis, clinical characteristics and treatment. Vasa. 2007;36(2):81-9. Review.
13. Hewins P, Tervaert JWC, Savage COS, Kallenberg CGM. Is Wegener's granulomatosis an autoimmune disease? Curr Opin Rheumatol. 2000;12(1):3-10.
14. Stein SL, Miller LC, Konnikov M. Wegerner's granulomatosis: case report and literature review. Pediatr Dermatol. 1998;15(5):352-6.
15. Patten SF, Tomecki KJ. Wegener's granulomatosis: cutaneous and oral mucosal disease. J Am Acad Dermatol. 1993;28(5 Pt 1):710-8.
16. Pakrou N, Selva D, Leibovitch I. Wegener's granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum. 2006;35(5):284-92. Review.
17. Comfere NI, Macaron NC, Gibson LE. Cutaneous manifestations of Wegener's granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status. J Cutan Pathol. 2007;34(10):739-47.
18. Barksdale SK, Hallahan CW, Kerr GS, Fauci AS, Stern JB, Travis WD. Cutaneous pathology in Wegener's granulomatosis. A clinicopathologic study of 75 biopsies in 46 patients. Am J Surg Pathol. 1995;19(2):161-72.
19. Savage COS, Winearls CG, Evans DJ, et al. Microscopic polyarteritis: presentation, pathology, and prognosis. QJ Med. 1985;56:467-83.
20. Haworth SJ, Savage CO, Carr D, Hughes JM, Rees AJ. Pulmonary haemorrhage complicating Wegener's granulomatosis and microscopic polyarteritis. Br Med J (Clin Res Ed). 1985;290(6484): 1775-8.
21. Metaxaris G, Prokopakis EP, Karatzanis AD, Sakelaris G, Heras P, Velegrakis GA, et al. Otolaryngologic manifestations of small vessel vasculitis. Auris Nasus Larynx. 2002;29(4):353-6.
22. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187-
23. Keogh KA, Specks U. Churg-Strauss syndrome: update on clinical, laboratory and therapeutic aspects. Sarcoidosis Vasc Diffuse Lung Dis. 2006;23(1):3-12.
24. Garini G, Corradi D, Vaglio A, Buzio C. Churg-Strauss syndrome. Recenti Prog Med. 2003;94(12):573-81.
25. Sergent JS, Cockshin MD, Christian CL, et al. Vasculitis with hepatitis B antigenemia: long-term observation in nine patients. Medicine (Baltimore). 1976;55:1-18.
26. Garcia G. Allergy-related hypereosinophilia. Presse Med. 2006;35(1 Pt 2):135-43.
27. Pagnoux C, Guilpain P, Guillevin L. Churg-Strauss syndrome. Curr Opin Rheumatol. 2007;19(1):25-32.
28. Crowson AN, Mihm MC Jr, Magro CM. Cutaneous vasculitis: a review. J Cutan Pathol. 2003;30(3):161-73. Review.
29. Schultz H, Weiss J, Carroll SF, Gross WL. Antineutrophil cytoplasmic antibodies: major autoantigens, pathophysiology, and disease associations. Semin Arthritis Rheum. 1995;25(3):143-59. Review.
30. Sandborn WJ. Serologic markers in inflammatory bowel disease: state of the art. RevGastroenterolDisord. 2004;4(4):167-74. Review.
31. Terjung B, Spengler U. Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases. Clin Rev Allergy Immunol. 2005;28(2):115-33. Review.
32. Savage CO. The evolving pathogenesis of systemic vasculitis. Clin Med. 2002;2(5):458-64. Review.
33. Di Cosola M, Turco M, Acero J, Navarro-Vila C, Cortelazzi R. Cocaine-related syndrome and palatal reconstruction: report of a series of cases. Int J Oral Maxillofac Surg. 2007;36(8):721-7. Epub 2007 Jul 20.
34. Scheenstra RJ, van Buren M, Koopman JP. A patient with both cocaine-induced nasal septum destruction and antibodies against anti-neutrophil cytoplasmic antibodies (ANCA); potential confusion with Wegener's disease. Ned Tijdschr Geneeskd. 2007;151(43):2395-9. Dutch. Erratum in: Ned Tijdschr Geneeskd. 2007 Nov 24;151(47):2644.
35. Rashid RM, Khachemoune A. Trigeminal trophic syndrome. J Eur Acad Dermatol Venereol. 2007;21(6):725-31. Review.
36. Monrad SU, Terrell JE, Aronoff DM. The trigeminal trophic syndrome: an unusual cause of nasal ulceration. J Am Acad Dermatol. 2004;50:949-52.
37. Rapini RP, Warner NB. Relapsing polychondritis. Clin Dermatol. 2006;24(6):482-5. Review.
38. Cohen PR. Paraneoplastic relapsing polychondritis. Arch Dermatol. 2007;143(7):949-50.
39. Yanagi T, Matsumura T, Kamekura R, Sasaki N, Hashino S. Relapsing polychondritis and malignant lymphoma: is polychondritis paraneoplastic? Arch Dermatol. 2007;143(1):89-90.
40. Kötter I, Deuter C, Günaydin I, Zierhut M. MAGIC or not MAGIC-does the MAGIC (mouth and genital ulcers with inflamed cartilage) syndrome really exist? A case report and review of the literature. Clin Exp Rheumatol. 2006;24(5 Suppl 42):S108-12. Review. Erratum in: Clin Exp Rheumatol. 2007 May-Jun;25(3):507-8.
41. Liebow AA, Carrington CRB, Friedman PJ. Lymphomatoid granulomatosis. Human Pathol. 1972;3(4):457-558.
42. Veltri RW, Raich PC, McClung JE, Shah SH, Sprinkle PM. Lymphomatoid granulomatosis and Epstein Barr virus. Cancer. 1982;50:1513.
43. Medeiros LJ, Jaffe ES, Chen YY, Weiss LM. Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am J Surg Pathol. 1992;16(5):439-47.
44. Peiper S. Angiocentric lymphoproliferative disorders of the respiratory system: incrimination of Epstein Barr virus in pathogenesis. Blood. 1993;82(3):687-9.
45. Guinee D Jr, Jaffe E, Kingma D, et al. Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am J Surg Pathol. 1994;18:753-64.
46. Lin BT. Lymphomatoid granulomatosis. Am J Surg Pathol. 1999;23(9):1162-3.
47. McNiff JM, Cooper D, Howe G, et al. Lymphomatoid granulomatosis of the skin and lung. An angiocentric T-cell-rich B-cell lymphoproliferative disorder. Arch Dermatol. 1996;132(12): 1464-70.
48. Haque AK, Myers JL, Hudnall SD, et al. Pulmonary lymphomatoid granulomatosis in acquired immunodeficiency syndrome: lesions with Epstein-Barr virus infection. Mod Pathol. 1998;11(4):347-56.
49. Lipford EF Jr, Margolick JB, Longo DL, Fauci AS, Jaffe ES. Angiocentric immunoproliferative lesions: A clinicopathologic spectrum of post thymic T cell proliferations. Blood. 1988; 72:1674.
50. Jaffe ES, Wilson WH. Lymphomatoid granulomatosis: pathogenesis, pathology, and clinical implications. Cancer Surv. 1997;30:233-48.
51. Katzenstein ALA, Carrington CB, Liebow AA. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer. 1979;43:360-72.
52. Tas S, Simonart T, Dargent J, Kentos A, Antoine M, Knoop C, Estenne M, De Dobbeleer G. Primary and isolated cutaneous lymphomatoid granulomatosis following heart-lung transplantation. Ann Dermatol Venereol. 2000;127(5):488-91.
53. Sebire NJ, Haselden S, Malone M, Davies EG, Ramsay AD. Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy. J Clin Pathol. 2003;56(7):555-7.
54. Saxena A, Dyker KM, Angel S, Moshynska O, Dharampaul S, Cockroft DW. Posttransplant diffuse large B-cell lymphoma of "lymphomatoid granulomatosis" type. Virchows Arch. 2002;441 (6):622-8.
55. Teruya-Feldstein J, Jaffe ES, Burd PR, et al. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood. 1997;90(10):4099-105.
56. Angel CA, Slater DN, Royds JA, et al. Epstein-Barr virus in cutaneous lymphomatoid granulomatosis. Histopathology. 1994; 25(6):545-8.
57. Jaffe ES, Chan JK, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20(1):103-11.
58. Wilson WH, Kingma DW, Raffeld M, et al. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. Blood. 1996;87(11):4531-7.
59. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood. 1994;84:1361.
60. Jaffe ES, Krenacs L, Raffeld M. Classification of T-cell and NKcell neoplasms based on the REAL classification. Ann Oncol. 1997;8(Suppl 2):17-24.
61. Jaffe ES, Sander CA, Flaig MJ. Cutaneous lymphomas: a proposal for a unified approach to classification using the R.E.A.L./ WHO classification. Ann Oncol. 2000;11(Suppl 1):17-21.
62. Greer JP, Kinney MC, Loughran TP Jr. T cell and NK cell lymphoproliferative disorders. Hematology (Am Soc Hematol Educ Program). 2001;259-81.
63. Hirakawa S, Kuyama M, Takahashi S, et al. Nasal and nasal-type natural killer/T-cell lymphoma. J Am Acad Dermatol. 1999; 40(2 Pt 1):268-72.
64. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia. 2005;19(12):2186-94.
65. Nava VE, Jaffe ES. The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol. 2005;12(1):27-34.
66. Cheung MM, Chan JK, Wong KF. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias. Semin Hematol. 2003;40(3):221-32.
67. Santucci M, Pimpinelli N, Massi D, Kadin ME, Meijer CJ, Muller-Hermelink HK, et al. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC cutaneous lymphoma task force workshop. Cancer. 2003;97(3):610-27.
68. Petrella T, Comeau MR, Maynadie M, et al. Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002;26(7):852-62.
69. Petrella T, Bagot M, Willemze R, et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 2005;123(5):662-75.
70. Aviles A, Diaz NR, Neri N, et al. Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients. Clin Lab Haematol. 2000;22(4):215-20.
71. Hallett WH, Murphy WJ. Natural killer cells: biology and clinical use in cancer therapy. Cell Mol Immunol. 2004;1(1):12-21.
72. Farag SS, Caligiuri MA. Human natural killer cell development and biology. Blood Rev. 2005.
73. Gaal K, Sun NC, Hernandez AM, Arber DA. Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol. 2000; 24(11):1511-7.
74. Gaal K, Weiss LM, Chen WG, et al. Epstein-Barr virus nuclear antigen (EBNA)-1 carboxy-terminal and EBNA-4 sequence polymorphisms in nasal natural killer/T-cell lymphoma in the United States. Lab Invest. 2002;82(7):957-62.
75. Siu LL, Chan V, Chan JK, Wong KF, Liang R, Kwong YL. Consistent patterns of allelic loss in natural killer cell lymphoma. Am J Pathol. 2000;157(6):1803-9.